The glycosphingolipid P1 is an ovarian cancer-associated carbohydrate antigen involved in migration

British Journal of Cancer

Volumn 111, Issue 8, 2014, Pages 1634-1645

  Jacob, F ^a,b   Anugraham, M ^c   Pochechueva, T ^a   Tse, B W C ^b,d   Alam, S ^a   Guertler, R ^a,b   Bovin, N V ^e   Fedier, A ^a   Hacker, N F ^f   Huflejt, M E ^g   Packer, N ^c   Heinzelmann Schwarz, V A ^a,b,f  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^f ROYAL HOSPITAL FOR WOMEN   (Australia)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; GLYCOSPHINGOLIPID; TUMOR ANTIGEN;

AFFINITY CHROMATOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METASTASIS; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; FEMALE; FLOW CYTOMETRY; GLYCOSPHINGOLIPIDS; HUMANS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS;

EID: 84908687277     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.455     Document Type: Article

References (59)

1. Boes M (2000) Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37(18): 1141-1149.
2. Bovin N, Obukhova P, Shilova N, Rapoport E, Popova I, Navakouski M, Unverzagt C, Vuskovic M, Huflejt M (2012) Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies? Biochim Biophys Acta 1820(9): 1373-1382.
3. Bovin NV (2013) Natural antibodies to glycans. Biochemistry (Moscow) 78(7): 786-797.
4. Brandlein S, Beyer I, Eck M, Bernhardt W, Hensel F, Muller-Hermelink HK, Vollmers HP (2003) Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1. Cancer Res 63(9): 2052-2061.
5. Brandlein S, Eck M, Strobel P, Wozniak E, Muller-Hermelink HK, Hensel F, Vollmers HP (2004a) PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursors. Hum Antibodies 13(4): 97-104.
6. Brandlein S, Pohle T, Vollmers C, Wozniak E, Ruoff N, Muller-Hermelink HK, Vollmers HP (2004b) CFR-1 receptor as target for tumor-specific apoptosis induced by the natural human monoclonal antibody PAM-1. Oncol Rep 11(4): 777-784.
7. Chai W, Piskarev V, Lawson AM (2001) Negative-ion electrospray mass spectrometry of neutral underivatized oligosaccharides. Anal Chem 73(3): 651-657.
8. Chang WW, Lee CH, Lee P, Lin J, Hsu CW, Hung JT, Lin JJ, Yu JC, Shao LE, Yu J, Wong CH, Yu AL (2008) Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proc Natl Acad Sci USA 105(33): 11667-11672.
9. Chmiela M, Wadstrom T, Folkesson H, Planeta Malecka I, Czkwianianc E, Rechcinski T, Rudnicka W (1998) Anti-Lewis X antibody and Lewis X-anti-Lewis X immune complexes in Helicobacter pylori infection. Immunol Lett 61(2-3): 119-125.
10. Desai PR, Ujjainwala LH, Carlstedt SC, Springer GF (1995) Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection. J Immunol Methods 188(2): 175-185.
11. Desselle A, Chaumette T, Gaugler MH, Cochonneau D, Fleurence J, Dubois N, Hulin P, Aubry J, Birkle S, Paris F (2012) Anti-gb3 monoclonal antibody inhibits angiogenesis and tumor development. PLoS One 7(11): e45423.
12. Domon B, Costello CE (1988) Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry 27(5): 1534-1543.
13. Everest-Dass AV, Jin D, Thaysen-Andersen M, Nevalainen H, Kolarich D, Packer NH (2012) Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology 22(11): 1465-1479.
14. Falguieres T, Maak M, von Weyhern C, Sarr M, Sastre X, Poupon MF, Robine S, Johannes L, Janssen KP (2008) Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogenbased delivery tool. Mol Cancer Ther 7(8): 2498-2508.
15. Feldman GB (1975) Lymphatic obstruction in carcinomatous ascites. Cancer Res 35(2): 325-332.
16. Gilewski T, Ragupathi G, Bhuta S, Williams LJ, Musselli C, Zhang XF, Bornmann WG, Spassova M, Bencsath KP, Panageas KS, Chin J, Hudis CA, Norton L, Houghton AN, Livingston PO, Danishefsky SJ (2001) Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci USA 98(6): 3270-3275.
17. Gillard BK, Thomas JW, Nell LJ, Marcus DM (1989) Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus. J Immunol 142(11): 3826-3832.
18. Gupta V, Bhinge KN, Hosain SB, Xiong K, Gu X, Shi R, Ho MY, Khoo KH, Li SC, Li YT, Ambudkar SV, Jazwinski SM, Liu YY (2012) Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells. J Biol Chem 287(44): 37195-37205.
19. Hakomori S (1998) Cancer-associated glycosphingolipid antigens: their structure, organization, and function. Acta Anat 161(1-4): 79-90.
20. Hakomori S, Wang SM, Young Jr. WW (1977) Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. Proc Natl Acad Sci USA 74(7): 3023-3027.
21. Hakomori SI (2010) Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett 584(9): 1901-1906.
22. Huflejt ME, Vuskovic M, Vasiliu D, Xu H, Obukhova P, Shilova N, Tuzikov A, Galanina O, Arun B, Lu K, Bovin N (2009) Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges. Mol Immunol 46(15): 3037-3049.
23. Jacob F, Goldstein DR, Bovin NV, Pochechueva T, Spengler M, Caduff R, Fink D, Vuskovic MI, Huflejt ME, Heinzelmann-Schwarz V (2012) Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. Int J Cancer 130(1): 138-146.
24. Jacob F, Meier M, Caduff R, Goldstein D, Pochechueva T, Hacker N, Fink D, Heinzelmann-Schwarz V (2011a) No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecol Oncol 121(3): 487-491.
25. Jacob F, Tse BWC, Guertler R, Nixdorf S, Bovin NV, Hacker N, Heinzelmann-Schwarz V (2011b) P1 antigen is present on the serous ovarian cancer cell line, IGROV1, correlating with A4GALT overexpression and altered cell behaviour. Glycobiology 21(11): 1454-1531.
26. Janssen KP, Vignjevic D, Boisgard R, Falguieres T, Bousquet G, Decaudin D, Dolle F, Louvard D, Tavitian B, Robine S, Johannes L (2006) In vivo tumor targeting using a novel intestinal pathogen-based delivery approach. Cancer Res 66(14): 7230-7236.
27. Jarvis WD, Grant S, Kolesnick RN (1996) Ceramide and the induction of apoptosis. Clin Cancer Res 2(1): 1-6.
28. Johansson D, Andersson C, Moharer J, Johansson A, Behnam-Motlagh P (2010) Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells. Br J Cancer 102(2): 383-391.
29. Karlsson H, Halim A, Teneberg S (2010) Differentiation of glycosphingolipidderived glycan structural isomers by liquid chromatography/mass spectrometry. Glycobiology 20(9): 1103-1116.
30. Kasahara K, Sanai Y (1999) Possible roles of glycosphingolipids in lipid rafts. Biophys Chem 82(2-3): 121-127.
31. Ke N, Wang X, Xu X, Abassi YA (2011) The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol 740: 33-43.
32. Kovbasnjuk O, Mourtazina R, Baibakov B, Wang T, Elowsky C, Choti MA, Kane A, Donowitz M (2005) The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc Natl Acad Sci USA 102(52): 19087-19092.
33. Lavoue V, Thedrez A, Leveque J, Foucher F, Henno S, Jauffret V, Belaud-Rotureau MA, Catros V, Cabillic F (2013) Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer. J Transl Med 11: 147.
34. Li J, Lee AS (2006) Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6(1): 45-54.
35. Malickova K, Lukas M, Donoval R, Sandova P, Janatkova I (2006) Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice? Clin Lab 52(11-12): 631-638.
36. Martin F, Kearney JF (2001) B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 13(2): 195-201.
37. Oyelaran O, McShane LM, Dodd L, Gildersleeve JC (2009) Profiling human serum antibodies with a carbohydrate antigen microarray. J Proteome Res 8(9): 4301-4310.
38. Ozols RF (2006) Challenges for chemotherapy in ovarian cancer. Ann Oncol 17(Suppl 5): v181-v187.
39. Panjwani N, Zhao Z, Ahmad S, Yang Z, Jungalwala F, Baum J (1995) Neolactoglycosphingolipids, potential mediators of corneal epithelial cell migration. J Biol Chem 270(23): 14015-14023.
40. Pochechueva T, Chinarev A, Spengler M, Korchagina E, Heinzelmann-Schwarz V, Bovin N, Rieben R (2011a) Multiplex suspension array for human anti-carbohydrate antibody profiling. Analyst 136(3): 560-569.
41. Pochechueva T, Jacob F, Fedier A, Heinzelmann-Schwarz V (2012) Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel-high throughput approaches. Metabolites 2(4): 913-939.
42. Pochechueva T, Jacob F, Goldstein DR, Huflejt ME, Chinarev A, Caduff R, Fink D, Hacker N, Bovin NV, Heinzelmann-Schwarz V (2011b) Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconj J 28(8-9): 507-517.
43. Pohle T, Brandlein S, Ruoff N, Muller-Hermelink HK, Vollmers HP (2004) Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulation. Cancer Res 64(11): 3900-3906.
44. Robbe C, Capon C, Coddeville B, Michalski JC (2004) Diagnostic ions for the rapid analysis by nano-electrospray ionization quadrupole time-of-flight mass spectrometry of O-glycans from human mucins. Rapid Commun Mass Spectrom 18(4): 412-420.
45. Rodriguez-Zhurbenko N, Martinez D, Blanco R, Rondon T, Grinan T, Hernandez AM (2013) Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties. Eur J Immunol 43(3): 826-837.
46. Roy AM, Tiwari KN, Parker WB, Secrist III JA, Li R, Qu Z (2006) Antiangiogenic activity of 4'-thio-beta-D-arabinofuranosylcytosine. Mol Cancer Ther 5(9): 2218-2224.
47. Solly K, Wang X, Xu X, Strulovici B, Zheng W (2004) Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol 2(4): 363-372.
48. Springer GF (1984) T and Tn, general carcinoma autoantigens. Science 224(4654): 1198-1206.
49. Springer GF, Chandrasekaran EV, Desai PR, Tegtmeyer H (1988) Blood group Tn-active macromolecules from human carcinomas and erythrocytes: characterization of and specific reactivity with mono-and poly-clonal anti-Tn antibodies induced by various immunogens. Carbohydr Res 178: 271.
50. Tamsma JT, Keizer HJ, Meinders AE (2001) Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited. Ann Oncol 12(10): 1353-1357.
51. Taniguchi N, Yokosawa N, Narita M, Mitsuyama T, Makita A (1981) Expression of Forssman antigen synthesis and degradation in human lung cancer. J Natl Cancer Inst 67(3): 577-583.
52. Thuresson B, Westman JS, Olsson ML (2011) Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups. Blood 117(2): 678-687.
53. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI (2008) Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci USA 105(6): 1925-1930.
54. Viau M, Zouali M (2005) B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol 114(1): 17-26.
55. Viel T, Dransart E, Nemati F, Henry E, Theze B, Decaudin D, Lewandowski D, Boisgard R, Johannes L, Tavitian B (2008) In vivo tumor targeting by the B-subunit of shiga toxin. Mol Imaging 7(6): 239-247.
56. Vollmers HP, Brandlein S (2007) Natural antibodies and cancer. J Autoimmun 29(4): 295-302.
57. Wang CC, Huang YL, Ren CT, Lin CW, Hung JT, Yu JC, Yu AL, Wu CY, Wong CH (2008) Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci USA 105(33): 11661-11666.
58. Wenk J, Andrews PW, Casper J, Hata J, Pera MF, von Keitz A, Damjanov I, Fenderson BA (1994) Glycolipids of germ cell tumors: extended globoseries glycolipids are a hallmark of human embryonal carcinoma cells. Int J Cancer 58(1): 108-115.
59. Young Jr. WW, Hakomori SI, Levine P (1979) Characterization of anti-Forssman (anti-Fs) antibodies in human sera: their specificity and possible changes in patients with cancer. J Immunol 123(1): 92-96.